[1]

Peiris JSM, Guan Y, Yuen KY. 2004. Severe acute respiratory syndrome. Nature Medicine 10:S88−S97

doi: 10.1038/nm1143
[2]

Cui J, Li F, Shi ZL. 2019. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17(3):181−192

doi: 10.1038/s41579-018-0118-9
[3]

Hu B, Guo H, Zhou P, Shi ZL. 2021. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology 19(3):141−154

doi: 10.1038/s41579-020-00459-7
[4]

Wang Y, Xu B, Ma S, Wang H, Shang L, et al. 2022. Discovery of SARS-CoV-2 3CLPro peptidomimetic inhibitors through the catalytic dyad histidine-specific protein-ligand interactions. International Journal of Molecular Sciences 23(4):2392

doi: 10.3390/ijms23042392
[5]

Liu Y, Liang C, Xin L, Ren X, Tian L, et al. 2020. The development of coronavirus 3C-like protease (3CLPro) inhibitors from 2010 to 2020. European Journal of Medicinal Chemistry 206:112711

doi: 10.1016/j.ejmech.2020.112711
[6]

Zhong L, Lopez D, Pei S, Gao J. 2024. Healthcare system resilience and adaptability to pandemic disruptions in the United States. Nature Medicine 30(8):2311−2319

doi: 10.1038/s41591-024-03103-6
[7]

Jefferson T, Spencer EA, Brassey J, Heneghan C. 2021. Viral cultures for coronavirus disease 2019 infectivity assessment: a systematic review. Clinical Infectious Diseases 73(11):e3884−e3899

doi: 10.1093/cid/ciaa1764
[8]

Quijano-Rubio A, Yeh HW, Park J, Lee H, Langan RA, et al. 2021. De novo design of modular and tunable protein biosensors. Nature 591(7850):482−487

doi: 10.1038/s41586-021-03258-z
[9]

de Sousa KAF, Nonaka CKV, Khouri R, Gurgel Rocha CA, Regis-Silva CG, et al. 2023. Rapid detection of SARS-CoV-2 based on the LAMP assay associated with the CRISPRCas12a system. Diagnostics 13(13):2233

doi: 10.3390/diagnostics13132233
[10]

Macedo ACL, Prestes GDS, Colonetti T, Candido ACR, Uggioni MLR, et al. 2022. A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19. Journal of Clinical Virology 148:105121

doi: 10.1016/j.jcv.2022.105121
[11]

Yao X, Xu H, Du Q, Lu X, Wang Q. 2025. A novel method for detecting SARS-CoV-2 IgM and IgG based on the gold immune chromatography assay. Scientific Reports 15:4995

doi: 10.1038/s41598-025-89012-1
[12]

Chen Y, Liu Q, Guo D. 2020. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology 92(10):2249

doi: 10.1002/jmv.26234
[13]

Xue X, Yu H, Yang H, Xue F, Wu Z, et al. 2008. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. Journal of Virology 82(5):2515−2527

doi: 10.1128/jvi.02114-07
[14]

Ullrich S, Nitsche C. 2020. The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters 30(17):127377

doi: 10.1016/j.bmcl.2020.127377
[15]

Wang H, He S, Deng W, Zhang Y, Li G, et al. 2020. Comprehensive insights into the catalytic mechanism of middle east respiratory syndrome 3C-like protease and severe acute respiratory syndrome 3C-like protease. ACS Catalysis 10(10):5871−5890

doi: 10.1021/acscatal.0c00110
[16]

Kneller DW, Zhang Q, Coates L, Louis JM, Kovalevsky A. 2021. Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography. IUCrJ 8(6):973−979

doi: 10.1107/s2052252521010113
[17]

Dauparas J, Anishchenko I, Bennett N, Bai H, Ragotte RJ, et al. 2022. Robust deep learning-based protein sequence design using ProteinMPNN. Science 378(6615):49−56

doi: 10.1126/science.add2187
[18]

Loshbaugh AL, Kortemme T. 2020. Comparison of Rosetta flexible-backbone computational protein design methods on binding interactions. Proteins: Structure, Function, and Bioinformatics 88(1):206−226

doi: 10.1002/prot.25790
[19]

Maguire JB, Haddox HK, Strickland D, Halabiya SF, Coventry B, et al. 2021. Perturbing the energy landscape for improved packing during computational protein design. Proteins: Structure, Function, and Bioinformatics 89(4):436−449

doi: 10.1002/prot.26030
[20]

Rawson JMO, Duchon A, Nikolaitchik OA, Pathak VK, Hu WS. 2021. Development of a cell-based luciferase complementation assay for identification of SARS-CoV-2 3CLPro inhibitors. Viruses 13(2):173

doi: 10.3390/v13020173
[21]

Kilianski A, Mielech AM, Deng X, Baker SC. 2013. Assessing activity and inhibition of middle east respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. Journal of Virology 87(21):11955−11962

doi: 10.1128/jvi.02105-13
[22]

Chen KY, Krischuns T, Varga LO, Harigua-Souiai E, Paisant S, et al. 2022. A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLPro inhibitors. Antiviral Research 201:105272

doi: 10.1016/j.antiviral.2022.105272
[23]

Dagliyan O, Krokhotin A, Ozkan-Dagliyan I, Deiters A, Der CJ, et al. 2018. Computational design of chemogenetic and optogenetic split proteins. Nature Communications 9:4042

doi: 10.1038/s41467-018-06531-4
[24]

Pahmeier F, Neufeldt CJ, Cerikan B, Prasad V, Pape C, et al. 2021. A versatile reporter system to monitor virus-infected cells and its application to dengue virus and SARS-CoV-2. Journal of Virology 95(4):e01715−e01720

doi: 10.1128/jvi.01715-20
[25]

Froggatt HM, Heaton BE, Heaton NS. 2020. Development of a fluorescence-based, high-throughput SARS-CoV-2 3CLpro Reporter assay. Journal of Virology 94(22):e01265−e01220

doi: 10.1128/jvi.01265-20
[26]

Zhang Q, Schepis A, Huang H, Yang J, Ma W, et al. 2019. Designing a green fluorogenic protease reporter by flipping a beta strand of GFP for imaging apoptosis in animals. Journal of the American Chemical Society 141(11):4526−4530

doi: 10.1021/jacs.8b13042
[27]

Noske GD, de Souza Silva E, de Godoy MO, Dolci I, Fernandes RS, et al. 2023. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry 299(3):103004

doi: 10.1016/j.jbc.2023.103004
[28]

Dauparas J, Lee GR, Pecoraro R, An L, Anishchenko I, et al. 2025. Atomic context-conditioned protein sequence design using LigandMPNN. Nature Methods 22(4):717−723

doi: 10.1038/s41592-025-02626-1
[29]

An L, Said M, Tran L, Majumder S, Goreshnik I, et al. 2024. Binding and sensing diverse small molecules using shape-complementary pseudocycles. Science 385(6706):276−282

doi: 10.1126/science.adn3780
[30]

Moghadasi SA, Esler MA, Otsuka Y, Becker JT, Moraes SN, et al. 2022. Gain-of-signal assays for probing inhibition of SARS-CoV-2 MPro/3CLPro in living cells. mBio 13(3):e00784−e00722

doi: 10.1128/mbio.00784-22
[31]

Wu X, Go M, Nguyen JV, Kuchel NW, Lu BGC, et al. 2024. Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape. Nature Communications 15:6219

doi: 10.1038/s41467-024-50566-9
[32]

Xiong M, Su H, Zhao W, Xie H, Shao Q, et al. 2021. What coronavirus 3C-like protease tells us: from structure, substrate selectivity, to inhibitor design. Medicinal Research Reviews 41(4):1965−1998

doi: 10.1002/med.21783